Envestnet Asset Management
WVE icon

Envestnet Asset Management’s Wave Life Sciences WVE Stock Holding History

Envestnet Asset Management’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-38,546
Closed -$279K – 4974
2026
Q1 		$279K Sell
38,546
-1,274
-3% -$16.6K ﹤0.01% 4314
2025
Q4 		$677K Sell
39,820
-27
-0.1% -$274 ﹤0.01% 3495
2025
Q3 		$292K Buy
39,847
+2,866
+8% +$23.2K ﹤0.01% 4102
2025
Q2 		$240K Buy
36,981
+789
+2% +$5.21K ﹤0.01% 4142
2025
Q1 		$292K Buy
36,192
+3,861
+12% +$42.2K ﹤0.01% 3937
2024
Q4 		$400K Buy
32,331
+12,724
+65% +$170K ﹤0.01% 3710
2024
Q3 		$161K Buy
19,607
+4,035
+26% +$24.1K ﹤0.01% 4054
2024
Q2 		$77.7K Buy
+15,572
New +$88.8K ﹤0.01% 4080

Other funds holding WVE

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GP
GSK plc London $602M AUM
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RAM
Readystate Asset Management Chicago, Illinois $2.93B AUM 18.57% 1-Year Est. Return

Envestnet Asset Management's WVE Position: Q2 2026 in Review

Envestnet Asset Management sold out of Wave Life Sciences (WVE) in Q2 2026, closing a stake of 38,546 shares — an estimated $279K sold.

Envestnet Asset Management first reported a position in WVE in Q2 2024 and held it in 8 quarters. The position peaked at $677K in Q4 2025. 239 funds tracked by Wall St. Rank hold WVE as of Q2 2026.

  • Envestnet Asset Management reported no remaining Wave Life Sciences position as of Q2 2026 after selling out during the quarter.
  • Envestnet Asset Management sold 38,546 Wave Life Sciences shares in Q2 2026, an estimated $279K.
  • Envestnet Asset Management first reported a position in Wave Life Sciences in Q2 2024 and held it in 8 quarters.
  • Envestnet Asset Management's Wave Life Sciences position peaked at $677K in Q4 2025.
  • 239 funds tracked by Wall St. Rank held Wave Life Sciences as of Q2 2026.

Based on Envestnet Asset Management's 13F filing for Q2 2026, filed 3 Aug 2026.